TABLE 3.

Genetic distances among ocular, urogenital, and LGV disease groups for each pmp gene

Disease group and compound type	No. (SE; % change) of nucleotide or amino acid changes
	Ocular	Urogenital	Ocular	Urogenital
	pmpC			pmpE
Urogenital
Nucleotide	21.5 (3.6; 0.4)		119 (9.1; 4.3)
Amino acid	15.3 (2.7; 0.9)		43.3 (5.7; 4.7)
LGV
Nucleotide	41.8 (6.5; 0.8)	40.3 (5.2; 0.8)	115.9 (9.4; 4.2)	52.5 (5.0; 1.5)
Amino acid	32.8 (5.7; 1.9)	30.7 (4.8; 1.8)	45.8 (6.2; 5)	15.8 (2.9; 1.7)
	pmpH			pmpI
Urogenital
Nucleotide	145 (11.0; 4.9)		15.3 (3.2; 0.6)
Amino acid	37.3 (5.8; 3.8)		8.6 (2.5; 1.0)
LGV
Nucleotide	187.3 (13.1; 6.4)	168.2 (12.8; 5.7)	21.8 (4.5; 0.8)	22.5 (4.2; 0.9)
Amino acid	59.6 (7.1; 6.1)	42.3 (5.6; 4.3)	7.5 (2.5; 0.9)	7.5 (2.3; 0.9)